Can Abiomed sustain its impressive sales growth in FY 2019?

separator

by Kenny Dolgin, Data Insights, Guidepoint Abiomed, Inc. (NYSE: ABMD) is a leader in the percutaneous heart pump device market, having launched its first Impella device in 2008 and have since released four iterations with varying flow rates. From May 2013 to May 2018, Abiomed’s stock price delivered a 5-year CAGR of 75%, making it […]

Read More

Can Edwards Lifesciences Fend Off Medtronic?

separator

by Kenny Dolgin, Data Insights, Guidepoint Edwards Lifesciences Corp. (NYSE: EW) is a leader in the approximately $3 billion transcatheter heart valve (THV) market, having launched their first SAPIEN valve in the U.S. in 2011 and now having released their third generation valve. From 2013 to 2017, Edwards’ stock price delivered a 5-year CAGR of […]

Read More

Is Q4 2017 Another Inflection Point For Penumbra?

separator

by Kenny Dolgin, Data Insights, Guidepoint Penumbra Inc. (NYSE: PEN) is a key player in the treatment for ischemic stroke, having received FDA approval for the first aspiration-based thrombectomy system in 2007 and having since launched five new generations of the device. In the U.S., Penumbra caters to a total addressable market of approximately $1.5 […]

Read More

Consultants Call on Guidepoint

separator

Guidepoint works with over 1,000 clients, including 9 of the top 10 global consulting firms.   Our network is made up of over 440,000 Advisors covering all sectors, regions and relevant industries. These Advisors are C-Suite Decision Makers, Customers, Suppliers, Operations, Procurement, etc.   Our dedicated global servicing teams provide strategic recruiting resources and can […]

Read More

Hemophilia Treatment:
A Market Poised for Revolutionary Changes in 2018

separator

by Ken Wahl, Data Insights, Guidepoint Shire Plc’s (NYSE: SHPG) US hemophilia sales have faced much competition in recent years. In particular, their leading hemophilia A treatment Advate, an older, shorter-acting recombinant factor VIII, is facing many new US market entrants with longer half-lives. However, the global hemophilia portfolio including Adynovate has managed to maintain […]

Read More

Find an answer to every business question.
Here’s how.

separator

As an expert network, we’ve received a lot of requests that start with ”this is going to sound strange” or “you probably don’t know anyone”. Very rarely was that client right. With over 560,000 advisors and deep expertise in custom recruiting new experts, we have the tools and the people to get you answers to [...]

Read More

On-Demand Access To
Expert Insights

separator

When hours can make the difference between capitalizing on an opportunity or coming up empty handed, the ability to find accurate, timely insights is a critical advantage for businesses. Here’s how we help our clients get the right information to make decisions with confidence within that crucial time period. Through the unmatched speed of our offerings, […]

Read More

Top 5 Rules For Validating Business Insights

separator

With the rise of misinformation in all areas of mass media, the need for airtight credibility is now more crucial than ever before. Without it, it would be impossible to make the right decisions with the right insights. Client need: Identifying your business need and matching it to the right expert with the most relevant [...]

Read More

Make Curiosity Your Competitive Advantage

separator

There was a time when lack of information was a pressing business challenge. But, in the current climate of over-communication and alternative facts, the challenge for today’s decision makers isn’t finding information, but how to identify the right information.   In an era of self-selection and content curation, it’s easy to let overconfidence, lack of […]

Read More

Asking The Right Questions

separator

Originally published in Private Debt Investor © 2015 Private Debt Investor, PEI Media As direct lending attracts more potential customers, lenders are tapping vertical industry experts to help them efficiently assess opportunities. Michael Ferrari, head of new client development at Guidepoint, explores the trend. Direct lending continues to be identified as one of the most […]

Read More